Skip to main navigation Skip to search Skip to main content

A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease

  • Arnold E. Postlethwaite
  • , Kee Wong Weng
  • , Philip Clements
  • , Soumya Chatterjee
  • , Barri J. Fessler
  • , Andrew H. Kang
  • , Joseph Korn
  • , Maureen Mayes
  • , Peter A. Merkel
  • , Jerry A. Molitor
  • , Larry Moreland
  • , Naomi Rothfield
  • , Robert W. Simms
  • , Edwin A. Smith
  • , Robert Spiera
  • , Virginia Steen
  • , Kenneth Warrington
  • , Barbara White
  • , Frederick Wigley
  • , Daniel E. Furst

Research output: Contribution to journal › Article › peer-review

84   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science